Progress of related diseases features and prognostic evaluation of myelodysplastic syndromes / 白血病·淋巴瘤
Journal of Leukemia & Lymphoma
; (12): 143-144,153, 2018.
Article
en Zh
| WPRIM
| ID: wpr-691623
Biblioteca responsable:
WPRO
ABSTRACT
Myelodysplastic syndromes (MDS) characterized by the presence of ineffective hematopoiesis and an increased risk of transformation to acute myeloid leukemia (AML), is a group of clonal disorders deriving from the hematopoietic stem/progenitor cells. The 59th American Society of Hematology (ASH) Annual Meeting introduced detailed reports on disease genes, the molecular mechanism, therapeutic targets, new drugs and clinical research of MDS. Combined with reports in the 59th ASH Annual Meeting, this article summarizes the latest progress of the related diseases features and prognostic evaluation of MDS.
Texto completo:
1
Índice:
WPRIM
Tipo de estudio:
Prognostic_studies
Idioma:
Zh
Revista:
Journal of Leukemia & Lymphoma
Año:
2018
Tipo del documento:
Article